Open AccessMEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration
Author(s) -
Scarlett J. Barker,
Ravikiran M. Raju,
Noah Milman,
Jun Wang,
José Dávila-Velderrain,
Fatima GunterRahman,
Cameron Parro,
P. Lorenzo Bozzelli,
Fatema Abdurrob,
Karim Abdelaal,
David A. Bennett,
Manolis Kellis,
LiHuei Tsai
Publication year - 2021
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.abd7695
Subject(s) - neurodegeneration , neuroscience , biology , cognitive decline , cognition , mef2 , population , disease , dementia , transcription factor , medicine , enhancer , genetics , gene , environmental health , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom